Pravala Pishti
Pravala Pishti is a bhasma, a mineral or metal preparation reduced to ash by repeated calcination. [Effect of Praval bhasma (Coral calx), a natural source of rich calcium on bone mineralization in rats](https://pubmed.ncbi.nlm.nih.gov/14527824/).
| Substance type | Mineral or metal preparation, not a plant |
|---|---|
| Also known as | Pravala Pishti, PravalaPishti |
Names and identification
| Language | Name |
|---|---|
| English | Pravala Pishti |
How does it work?
- Calcium supplementation: CaCO3 from coral provides bioavailable calcium for bone mineralization; the marine-derived form may have superior absorption compared to geological calcium carbonate due to trace mineral co-factors
- Acid-neutralizing antacid: Calcium carbonate directly neutralizes excess gastric HCl, providing rapid relief from hyperacidity - mechanistically identical to pharmaceutical antacids
- Pitta-pacifying and hemostatic: The cooling property reduces Pitta-related bleeding disorders; calcium is essential for the coagulation cascade, supporting the traditional use in bleeding conditions
Which traditional uses are supported by research?
- Calcium deficiency and bone disorders: Preclinical study (2003) demonstrated prevention of calcium and estrogen deficit bone loss; multicenter clinical study (2020) supported safety and efficacy in menopausal calcium management
- Hyperacidity (Amlapitta) and bleeding disorders (Raktapitta): The calcium carbonate content provides direct mechanistic validation for antacid use; calcium’s role in coagulation cascade supports the traditional hemostatic indication
What do recent clinical trials show?
- Reddy PN, Lakshmana M, Udupa UV 2003. Effect of Praval bhasma (Coral calx), a natural source of rich calcium on bone mineralization in rats. Pharmacological research. PMID 14527824 · doi:10.1016/s1043-6618(03)00224-x
Praval Bhasma was effective in the prevention of calcium and estrogen deficit bone loss in experimental models, supporting its use as a natural calcium supplement for bone health.
1 further claim previously listed here could not be traced to a published paper and has been removed. An absence here means we could not identify the source, not that no work exists.
Recent safety updates
- GENERALLY SAFE: Like Mukta Pishti, Pravala Pishti is a non-toxic mineral preparation containing no heavy metals when properly prepared - essentially a natural coral calcium supplement
- Dose-dependent side effects: Excess intake (>2500 mg/day) can cause abdominal distension, flatulence, loss of appetite, and risk of kidney stone formation due to hypercalcemia
- Environmental concern: Coral harvesting raises ecological sustainability questions; sourcing from sustainable or cultivated coral stocks is recommended
- Quality control: Marine-derived products should be tested for marine pollutants, microbiological contamination, and heavy metal residues; GMP-certified sourcing essential
What is it made of?
Mineral/Elemental Profile
- Primary component: Calcined mineral/metal oxide (after Shodhana and Marana)
- Particle size: Sub-micron to nanoparticle range
- Note: Exact composition depends on source material and preparation method
Analytical Methods: XRD, ICP-OES/ICP-MS, SEM-EDS, Particle size analysis, Namburi phased spot test
Dosage forms and preparation
Dosage Forms: Pishti, Bhasma (Pravala Bhasma also available)
Standard Dosage: 250–500 mg twice daily
Bioavailability: Excellent; coral calcium carbonate with natural marine mineral matrix — one of the most bioavailable calcium forms
Optimal Timing: With honey or Malai; with meals for calcium supplementation
Standardized Extract: Red coral pishti — cold-processed coral calcium
Shelf Life: Indefinite
Storage: Airtight, dry container
Marker Compounds: Calcium carbonate (85–90%), Magnesium (2–3%), Strontium, Iron, Trace elements (70+ from marine origin)
Quality Parameters: Calcium >30%, magnesium >1%, standard pishti tests, coral authentication (not synthetic), marine pollutant screening
Vehicle (Anupana): Honey, Gulkand, Malai, or pomegranate juice
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Other clinical studies and reviews8
- 2024. Lipid metabolism reprogramming in cardiac fibrosisTrends in endocrinology and metabolism: TEM. PMID 37949734 · doi:10.1016/j.tem.2023.10.004
- 2023. Morus alba: a comprehensive phytochemical and pharmacological reviewNaunyn-Schmiedeberg's archives of pharmacology. PMID 36877269 · doi:10.1007/s00210-023-02434-4
- 2022. Diuretics: a contemporary pharmacological classification?Naunyn-Schmiedeberg's archives of pharmacology. PMID 35294605 · doi:10.1007/s00210-022-02228-0
- 2020. Mechanical regulation of oligodendrocyte biologyNeuroscience letters. PMID 31838017 · doi:10.1016/j.neulet.2019.134673
- 2020. Down syndrome: A curative prospect?AIMS neuroscience. PMID 32607419 · doi:10.3934/Neuroscience.2020012
- 2014. Proliferative vitreoretinopathyDevelopments in ophthalmology. PMID 25196769 · doi:10.1159/000360466
- 2003. Effect of Praval bhasma (Coral calx), a natural source of rich calcium on bone mineralization in ratsPharmacological research. PMID 14527824 · doi:10.1016/s1043-6618(03)00224-x
- 2002. Myocardial remodelling: pharmacological targetsExpert opinion on investigational drugs. PMID 11996647 · doi:10.1517/13543784.11.5.661
Laboratory and animal studies4
- 2026. A whole-brain single-cell atlas of circadian neural activity in miceScience (New York, N.Y.). PMID 41231968 · doi:10.1126/science.aea3381
- 2024. Deep Learning-Driven Exploration of Pyrroloquinoline Quinone Neuroprotective Activity in Alzheimer's DiseaseAdvanced science (Weinheim, Baden-Wurttemberg, Germany). PMID 38454653 · doi:10.1002/advs.202308970
- 2023. Drug fever: a narrative reviewAnnals of clinical epidemiology. PMID 38504950 · doi:10.37737/ace.23013
- 2017. Principles of pharmacological research of nutraceuticalsBritish journal of pharmacology. PMID 28500635 · doi:10.1111/bph.13779
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.